BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
BCI
Ebola outbreak
Hantavirus
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Wednesday, June 24, 2026
Breaking News: Ongoing coverage of the Ebola outbreak
Breaking News: Ongoing coverage of the Ebola outbreak
Breaking News: Ongoing coverage of the Ebola outbreak
Home
»
Topics
» BioWorld Science, Endocrine/metabolic
BioWorld Science, Endocrine/metabolic
RSS
Amarin's pivotal phase III MARINE trial of AMR-101 meets primary endpoints
Nov. 29, 2010
Takeda applies to change Leuplin dosage and administration for CPP in Japan
Nov. 29, 2010
MAA submitted to EMA for taliglucerase alfa in Gaucher's disease
Nov. 29, 2010
Banyu Pharma patents new antagonists of peptide P518 receptor
Nov. 26, 2010
FDA approves testosterone replacement therapy Axiron
Nov. 24, 2010
Neurocrine Biosciences completes Daisy Petal trial of elagolix in endometriosis
Nov. 23, 2010
Omthera agrees with FDA on special protocol assessment for Epanova trial
Nov. 23, 2010
Anacetrapib is efficacious and safe in phase III DEFINE trial
Nov. 23, 2010
CTAP-201 shows promise in patients with secondary hyperparathyroidism on hemodialysis
Nov. 23, 2010
Ampla Pharmaceuticals identifies novel cyclic amides
Nov. 22, 2010
Previous
1
2
…
656
657
658
659
660
661
662
663
664
…
1797
1798
Next
RSS